Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Finance
  • Published:

Emerging company financing in global markets

Nature Biotechnology volume 17, pages 19–20 (1999)Cite this article

Abstract

Orthovita was the first US company to complete its IPO on the EASDAQ, and its experience offers a lesson for other companies in need of funds.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. vice president and chief financial officer of Orthovita, Inc., 45 Great Valley Parkway, Malvern, 19355, PA

    Joseph M. Paiva

Authors
  1. Joseph M. Paiva
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paiva, J. Emerging company financing in global markets. Nat Biotechnol 17 (Suppl 3), 19–20 (1999). https://doi.org/10.1038/9094

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/9094

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing